Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Khera

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
JAMA Cardiology|May 18, 2022
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National BiobankKiran J Biddinger, Sean J Jurgens, Dimitri Maamari, et al.
JACC. Advances|June 28, 2024
Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial HypercholesterolemiaLaurens F Reeskamp, Injeong Shim, Jacqueline S Dron, et al.
Nature Communications|October 18, 2023
Clinical utility of polygenic scores for cardiometabolic disease in ArabsInjeong Shim, Hiroyuki Kuwahara, NingNing Chen, et al.
Gastroenterology|December 14, 2020
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction StudyConnor A Emdin, Mary Haas, Veeral Ajmera, et al.
BMC Medical Genomics|October 2, 2021
Design and user experience testing of a polygenic score report: a qualitative study of prospective usersDeanna G Brockman, Lia Petronio, Jacqueline S Dron, et al.
Circulation Research|November 7, 2019
Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National BiobankSeung Hoan Choi, Sean J Jurgens, Lu-Chen Weng, et al.
JAMA|November 9, 2025
Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness StudyBrandon K Bellows, Yiyi Zhang, Natalia Ruiz-Negrón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 25, 2024
Polygenic risk, aspirin, and primary prevention of coronary artery diseaseChenglong Yu, Pradeep Natarajan, Aniruddh P Patel, et al.
Plos Genetics|September 1, 2022
Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's diseaseManish D Paranjpe, Mark Chaffin, Sohail Zahid, et al.
The New England Journal of Medicine|January 14, 2011
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosisAmit V Khera, Marina Cuchel, Margarita de la Llera-Moya, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
JAMA Cardiology|May 18, 2022
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National BiobankKiran J Biddinger, Sean J Jurgens, Dimitri Maamari, et al.
JACC. Advances|June 28, 2024
Polygenic Background Modifies Risk of Coronary Artery Disease Among Individuals With Heterozygous Familial HypercholesterolemiaLaurens F Reeskamp, Injeong Shim, Jacqueline S Dron, et al.
Nature Communications|October 18, 2023
Clinical utility of polygenic scores for cardiometabolic disease in ArabsInjeong Shim, Hiroyuki Kuwahara, NingNing Chen, et al.
Gastroenterology|December 14, 2020
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction StudyConnor A Emdin, Mary Haas, Veeral Ajmera, et al.
BMC Medical Genomics|October 2, 2021
Design and user experience testing of a polygenic score report: a qualitative study of prospective usersDeanna G Brockman, Lia Petronio, Jacqueline S Dron, et al.
Circulation Research|November 7, 2019
Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National BiobankSeung Hoan Choi, Sean J Jurgens, Lu-Chen Weng, et al.
JAMA|November 9, 2025
Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness StudyBrandon K Bellows, Yiyi Zhang, Natalia Ruiz-Negrón, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 25, 2024
Polygenic risk, aspirin, and primary prevention of coronary artery diseaseChenglong Yu, Pradeep Natarajan, Aniruddh P Patel, et al.
Plos Genetics|September 1, 2022
Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's diseaseManish D Paranjpe, Mark Chaffin, Sohail Zahid, et al.
The New England Journal of Medicine|January 14, 2011
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosisAmit V Khera, Marina Cuchel, Margarita de la Llera-Moya, et al.
Pageof 14